Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours
ALC's performance is driven by robust demand for the company's innovative products, balanced geographic footprint and strong execution by the team.
Alcon cuts 2024 forecasts, as slow US hits surgical unit
Eye-care group Alcon cut its 2024 forecasts and missed market expectations for third-quarter sales on Tuesday evening, as a soft U.S. market hit its surgical business.
Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Alcon (ALC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
What Analyst Projections for Key Metrics Reveal About Alcon (ALC) Q3 Earnings
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Alcon (ALC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
Reasons to Retain Alcon Stock in Your Portfolio for Now
Strong growth in the Surgical and Vision Care businesses raises investors' optimism for ALC.
Innovation Aids Alcon Stock's Growth Despite Macroeconomic Troubles
Banking on strong sales of its contact lenses and ocular health products, ALC is registering solid growth within Vision Care.
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
Bausch + Lomb stock surged Monday — briefly breaking out — on a report the company is working with advisors to explore a potential sale.
Alcon Analysts Increase Their Forecasts After Q2 Results
Alcon Inc. ALC reported mixed second-quarter results, after the closing bell on Tuesday.
Alcon Inc. (ALC) Q2 2024 Earnings Call Transcript
Alcon Inc. (NYSE:ALC ) Q2 2024 Earnings Conference Call August 21, 2024 8:00 AM ET Company Participants Dan Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Jeff Johnson - Baird Graham Doyle - UBS Veronika Dubajova - Citi Ryan Zimmerman - BTIG David Adlington - JPMorgan Patrick Wood - Morgan Stanley Jack Reynolds-Clark - RBC Capital Markets David Saxon - Needham & Company Anthony Petrone - Mizuho Group Larry Biegelsen - Wells Fargo Michael Sarcone - Jefferies Issie Kirby - Redburn Atlantic Richard Felton - Goldman Sachs Tom Stephan - Stifel Steven Lichtman - Oppenheimer & Company Brett Fishbin - KeyBanc Capital Markets Operator Greetings and welcome to the Alcon Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Alcon (ALC) Q2 Earnings Meet Estimates, Revenues Increase Y/Y
Alcon (ALC) delivers impressive growth in Implantables and Contact Lenses in the second quarter of 2024.
Alcon (ALC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Alcon (ALC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Alcon's (ALC) Market Share Gains, New Launches Aid Growth
Alcon (ALC) is witnessing growth in its over-the-counter portfolio, driven by favorable pricing and a sustained family of products.
